GM-CSF-Dependent Inflammatory Pathways.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 01 03 2019
accepted: 14 08 2019
entrez: 26 9 2019
pubmed: 26 9 2019
medline: 21 10 2020
Statut: epublish

Résumé

Pre-clinical models and clinical trials demonstrate that targeting the action of the cytokine, granulocyte macrophage-colony stimulating factor (GM-CSF), can be efficacious in inflammation/autoimmunity reinforcing the importance of understanding how GM-CSF functions; a significant GM-CSF-responding cell in this context is likely to be the monocyte. This article summarizes critically the literature on the downstream cellular pathways regulating GM-CSF interaction with monocytes (and macrophages), highlighting some contentious issues, and conclusions surrounding this biology. It also suggests future directions which could be undertaken so as to more fully understand this aspect of GM-CSF biology. Given the focus of this collection of articles on monocytes, the following discussion in general will be limited to this population or to its more mature progeny, the macrophage, even though GM-CSF biology is broader than this.

Identifiants

pubmed: 31552022
doi: 10.3389/fimmu.2019.02055
pmc: PMC6737278
doi:

Substances chimiques

Cytokines 0
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor 0
Granulocyte-Macrophage Colony-Stimulating Factor 83869-56-1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2055

Références

J Exp Med. 1999 Sep 20;190(6):875-80
pubmed: 10499925
Immunity. 2001 Oct;15(4):557-67
pubmed: 11672538
J Leukoc Biol. 2002 Mar;71(3):511-9
pubmed: 11867689
Trends Immunol. 2002 Aug;23(8):403-8
pubmed: 12133803
J Immunol. 2003 Sep 1;171(5):2374-83
pubmed: 12928384
J Exp Med. 1992 Dec 1;176(6):1693-702
pubmed: 1460426
Am J Hematol. 2004 Apr;75(4):179-89
pubmed: 15054806
J Immunol. 2004 Oct 1;173(7):4643-51
pubmed: 15383599
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15989-94
pubmed: 16236719
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16001-6
pubmed: 16243976
J Immunol. 2005 Nov 15;175(10):6570-9
pubmed: 16272311
EMBO J. 2006 Feb 8;25(3):479-89
pubmed: 16437163
J Immunol. 2007 Apr 15;178(8):5245-52
pubmed: 17404308
Nat Rev Immunol. 2008 Jul;8(7):533-44
pubmed: 18551128
Cell. 2008 Aug 8;134(3):496-507
pubmed: 18692472
J Exp Med. 2008 Sep 29;205(10):2281-94
pubmed: 18779348
Immunobiology. 2008;213(9-10):859-70
pubmed: 18926300
Blood. 2009 Apr 2;113(14):3190-7
pubmed: 19196868
Blood. 2010 Apr 22;115(16):3346-53
pubmed: 20173116
J Exp Med. 2010 May 10;207(5):953-61
pubmed: 20421390
Nat Immunol. 2011 Mar;12(3):231-8
pubmed: 21240265
Blood. 2011 May 12;117(19):5092-101
pubmed: 21389328
Nat Immunol. 2011 Jun;12(6):560-7
pubmed: 21516112
Arthritis Rheum. 2011 Aug;63(8):2340-51
pubmed: 21809323
PLoS One. 2011;6(10):e25812
pubmed: 22003407
PLoS One. 2011;6(10):e25660
pubmed: 22065991
Science. 2012 Feb 3;335(6068):597-601
pubmed: 22245738
Blood. 2012 Apr 12;119(15):3383-93
pubmed: 22323450
J Immunol. 2012 Jun 1;188(11):5752-65
pubmed: 22547697
Immunity. 2012 Jun 29;36(6):1031-46
pubmed: 22749353
J Exp Med. 2012 Jul 30;209(8):1505-17
pubmed: 22802353
Eur J Immunol. 2012 Nov;42(11):2889-900
pubmed: 22806691
Trends Immunol. 2013 Feb;34(2):81-9
pubmed: 23000011
Immunity. 2012 Dec 14;37(6):1116-29
pubmed: 23200826
Nat Immunol. 2013 Mar;14(3):187-9
pubmed: 23416664
PLoS Biol. 2013;11(3):e1001515
pubmed: 23526884
Diabetes. 2013 Oct;62(10):3394-403
pubmed: 23835343
J Exp Med. 2013 Sep 23;210(10):1977-92
pubmed: 24043763
Immunity. 2013 Oct 17;39(4):722-32
pubmed: 24076050
Nat Commun. 2013;4:2990
pubmed: 24356538
J Immunol. 2014 Mar 1;192(5):2202-9
pubmed: 24489100
Immunity. 2014 Feb 20;40(2):274-88
pubmed: 24530056
Nat Immunol. 2014 Apr;15(4):354-364
pubmed: 24562309
PLoS One. 2014 Mar 17;9(3):e91126
pubmed: 24637385
Arterioscler Thromb Vasc Biol. 2014 May;34(5):976-84
pubmed: 24651678
J Exp Med. 2014 Jun 2;211(6):1243-56
pubmed: 24821911
J Exp Med. 2014 Jun 30;211(7):1449-64
pubmed: 24935258
Sci Transl Med. 2014 Jun 18;6(241):241ra80
pubmed: 24944195
Immunity. 2014 Jul 17;41(1):14-20
pubmed: 25035950
J Exp Med. 1989 Sep 1;170(3):865-75
pubmed: 2504878
Nat Immunol. 2014 Nov;15(11):1026-37
pubmed: 25263125
Oncoimmunology. 2014 Aug 03;3(8):e953418
pubmed: 25610743
J Immunol. 2015 Mar 1;194(5):2424-38
pubmed: 25653427
Expert Rev Clin Immunol. 2015 Apr;11(4):457-65
pubmed: 25748625
Ann Rheum Dis. 2016 May;75(5):899-907
pubmed: 25923217
J Immunol. 2015 Jul 1;195(1):134-44
pubmed: 26019271
Immunity. 2015 Jun 16;42(6):1197-211
pubmed: 26084029
J Immunol. 2015 Sep 1;195(5):2442-51
pubmed: 26209622
Immunity. 2015 Sep 15;43(3):502-14
pubmed: 26341401
Trends Immunol. 2015 Oct;36(10):651-662
pubmed: 26431942
Nat Rev Rheumatol. 2016 Jan;12(1):37-48
pubmed: 26633290
Cell Res. 2016 Feb;26(2):151-70
pubmed: 26729620
Elife. 2016 Jan 18;5:e10066
pubmed: 26780670
Cell Rep. 2016 Jun 14;15(11):2462-74
pubmed: 27264183
Structure. 2016 Aug 2;24(8):1271-1281
pubmed: 27396825
J Immunol. 2016 Sep 1;197(5):2000-8
pubmed: 27474076
J Clin Invest. 2016 Sep 1;126(9):3453-66
pubmed: 27525438
J Exp Med. 2016 Sep 19;213(10):1983-98
pubmed: 27595596
Mucosal Immunol. 2017 May;10(3):705-715
pubmed: 27731325
Mol Cells. 2016 Oct;39(10):734-741
pubmed: 27788572
Immunity. 2016 Nov 15;45(5):963-973
pubmed: 27851925
Arthritis Res Ther. 2016 Dec 1;18(1):287
pubmed: 27908288
Immunity. 2016 Dec 20;45(6):1205-1218
pubmed: 28002729
Nat Rev Drug Discov. 2016 Dec 29;16(1):53-70
pubmed: 28031576
Front Immunol. 2017 Jan 16;7:680
pubmed: 28138327
Immunity. 2017 Feb 21;46(2):245-260
pubmed: 28228281
PLoS One. 2017 Jul 27;12(7):e0181985
pubmed: 28750033
Sci Rep. 2017 Aug 31;7(1):10211
pubmed: 28860566
RMD Open. 2017 Jul 13;3(1):e000487
pubmed: 28955490
J Exp Med. 2017 Nov 6;214(11):3293-3310
pubmed: 28978634
Immunity. 2017 Nov 21;47(5):903-912.e4
pubmed: 29126797
Blood Adv. 2017 Jun 07;1(14):947-960
pubmed: 29296736
Ther Adv Musculoskelet Dis. 2018 Feb;10(2):29-38
pubmed: 29387176
Front Immunol. 2018 Jan 29;9:31
pubmed: 29434585
Cell Death Dis. 2018 Feb 15;9(3):267
pubmed: 29449600
JCI Insight. 2018 Mar 22;3(6):
pubmed: 29563337
Arthritis Res Ther. 2018 Apr 5;20(1):62
pubmed: 29622035
Immunity. 2018 Jun 19;48(6):1220-1232.e5
pubmed: 29802020
Eur J Immunol. 2018 Sep;48(9):1522-1538
pubmed: 29953616
Front Immunol. 2018 Aug 28;9:1922
pubmed: 30210491
Int J Rheum Dis. 2019 Apr;22(4):646-653
pubmed: 30358109
J Immunol. 2018 Dec 15;201(12):3677-3682
pubmed: 30413670
Nat Immunol. 2019 Apr;20(4):397-406
pubmed: 30742078
J Immunol. 2019 May 15;202(10):3033-3040
pubmed: 30988114
J Immunol. 1988 Sep 1;141(5):1516-21
pubmed: 3137258
J Cell Physiol. 1980 Jun;103(3):435-45
pubmed: 6967488
Blood. 1980 Dec;56(6):947-58
pubmed: 7002232
J Immunol. 1993 Jan 15;150(2):579-84
pubmed: 7678276
Lancet. 1993 Aug 28;342(8870):536-9
pubmed: 8102674
J Leukoc Biol. 1994 Mar;55(3):355-61
pubmed: 8120453
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5592-6
pubmed: 8202532

Auteurs

John A Hamilton (JA)

The University of Melbourne, Department of Medicine, Royal Melbourne Hospital, Parkville, VIC, Australia.
Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, St. Albans, VIC, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH